{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_004936.3:c.1985A>T",
          "cDNA Change": {
            "transcript": "NM_004936.3",
            "ref": "A",
            "alt": "T",
            "position": "1985"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "662"
          },
          "Description in input context": "This variant leads to a non-conservative amino acid substitution."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003347"
  },
  "Experiment Method": [
    {
      "Assay Method": "RT-qPCR",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Fibroblasts from Parkinson's Disease patients",
        "Description": "RNA was extracted from patient-derived fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004936.3:c.1985A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "The PINK1 transcript levels were significantly reduced (p<0.01) in fibroblasts carrying the NM_004936.3:c.1985A>T variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent cell lines from different patients were used as biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each RT-qPCR reaction was performed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblasts from healthy controls were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No-template control (NTC) was included to rule out contamination."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by a post-hoc Tukey test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "PINK1 transcript levels greater than 1.5 relative to controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "PINK1 transcript levels below 1.5 relative to controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}